Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313642013> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W4313642013 endingPage "S16" @default.
- W4313642013 startingPage "S16" @default.
- W4313642013 abstract "Objective To investigate the effects of anti-epileptic drugs (AED) on the overall burden of disease in patients with neuro-autoimmune disease (NAD). Background AEDs have shown to provide benefits against neurological damage in patients with various neurological illnesses. However, the extent of AEDs role in neuroprotection and the prevention of additional comorbidity in patients with NAD has not been completely characterized. Design/Methods A retrospective analysis on 34464 patients hospitalized at a tertiary care center in a major metropolitan area was conducted. 3997 patients were on AED medications, while 30467 patients were not taking any AEDs (nAED). 190 patients had a NAD diagnosis. Patients with NAD were classified according to use of AED or nAED (aAED and anAED). The outcomes compared included prevalence of neurological complications defined as either seizure, blurry vision, delirium, or altered mental status, encephalopathy, length of stay, ICU admission, comorbidity, and death. Results There was no significant difference in the prevalence of NAD between patients in AED or nAED (0.75%, 0.52%, p > 0.05). Among patients with aAED and anAED, there was no significant difference in length of stay (8.7, 7.8, p > 0.5), ICU admission (26.7%, 12.5%, p > 0.05), prevalence of comorbidities (56.7%, 52.5%, p > 0.05), or mortality (6.7%, 3.1%, p > 0.3). 36% of aAED and 16.3% of anAED had high risk comorbidity (p < 0.05). The prevalence of overall neurological complications was 37% and 10% among aAED and anAED, respectively (p < 0.001). Patients in aAED had significantly higher encephalopathy compared to anAED at 23% and 3.8%, respectively (p < 0.0001). Conclusions These results suggest that AEDs may be associated with an increase in high-risk comorbidities and neurological complications including encephalopathy among patients with NAD. Work is in progress to assess the contribution of the primary diagnoses for which AEDs were prescribed on the burden of NAD." @default.
- W4313642013 created "2023-01-07" @default.
- W4313642013 creator A5015204599 @default.
- W4313642013 creator A5018973313 @default.
- W4313642013 creator A5037121187 @default.
- W4313642013 creator A5044169481 @default.
- W4313642013 creator A5066005384 @default.
- W4313642013 creator A5073348554 @default.
- W4313642013 creator A5079727646 @default.
- W4313642013 date "2022-12-05" @default.
- W4313642013 modified "2023-09-23" @default.
- W4313642013 title "Do Anti-Epileptic Drugs Increase High Risk Comorbidity Amongst Patients With Neuro-Autoimmune Disease?" @default.
- W4313642013 doi "https://doi.org/10.1212/01.wnl.0000903152.06982.75" @default.
- W4313642013 hasPublicationYear "2022" @default.
- W4313642013 type Work @default.
- W4313642013 citedByCount "0" @default.
- W4313642013 crossrefType "journal-article" @default.
- W4313642013 hasAuthorship W4313642013A5015204599 @default.
- W4313642013 hasAuthorship W4313642013A5018973313 @default.
- W4313642013 hasAuthorship W4313642013A5037121187 @default.
- W4313642013 hasAuthorship W4313642013A5044169481 @default.
- W4313642013 hasAuthorship W4313642013A5066005384 @default.
- W4313642013 hasAuthorship W4313642013A5073348554 @default.
- W4313642013 hasAuthorship W4313642013A5079727646 @default.
- W4313642013 hasBestOaLocation W43136420131 @default.
- W4313642013 hasConcept C118552586 @default.
- W4313642013 hasConcept C126322002 @default.
- W4313642013 hasConcept C187212893 @default.
- W4313642013 hasConcept C203014093 @default.
- W4313642013 hasConcept C2522874641 @default.
- W4313642013 hasConcept C2778186239 @default.
- W4313642013 hasConcept C2779134260 @default.
- W4313642013 hasConcept C2779159551 @default.
- W4313642013 hasConcept C2779753318 @default.
- W4313642013 hasConcept C2781460105 @default.
- W4313642013 hasConcept C71924100 @default.
- W4313642013 hasConcept C83455156 @default.
- W4313642013 hasConceptScore W4313642013C118552586 @default.
- W4313642013 hasConceptScore W4313642013C126322002 @default.
- W4313642013 hasConceptScore W4313642013C187212893 @default.
- W4313642013 hasConceptScore W4313642013C203014093 @default.
- W4313642013 hasConceptScore W4313642013C2522874641 @default.
- W4313642013 hasConceptScore W4313642013C2778186239 @default.
- W4313642013 hasConceptScore W4313642013C2779134260 @default.
- W4313642013 hasConceptScore W4313642013C2779159551 @default.
- W4313642013 hasConceptScore W4313642013C2779753318 @default.
- W4313642013 hasConceptScore W4313642013C2781460105 @default.
- W4313642013 hasConceptScore W4313642013C71924100 @default.
- W4313642013 hasConceptScore W4313642013C83455156 @default.
- W4313642013 hasIssue "23" @default.
- W4313642013 hasLocation W43136420131 @default.
- W4313642013 hasOpenAccess W4313642013 @default.
- W4313642013 hasPrimaryLocation W43136420131 @default.
- W4313642013 hasRelatedWork W1485395193 @default.
- W4313642013 hasRelatedWork W1964346564 @default.
- W4313642013 hasRelatedWork W2059218729 @default.
- W4313642013 hasRelatedWork W2081303432 @default.
- W4313642013 hasRelatedWork W2106310822 @default.
- W4313642013 hasRelatedWork W2115208698 @default.
- W4313642013 hasRelatedWork W2132819771 @default.
- W4313642013 hasRelatedWork W2155591130 @default.
- W4313642013 hasRelatedWork W2257017262 @default.
- W4313642013 hasRelatedWork W2993775212 @default.
- W4313642013 hasVolume "99" @default.
- W4313642013 isParatext "false" @default.
- W4313642013 isRetracted "false" @default.
- W4313642013 workType "article" @default.